|
Ranbaxy Launches Flotral Prescription Medicine For Prostate Gland Enlargement (BPH)OUR CORPORATE BUREAURanbaxy Laboratories: Newsroom > Press Releases > New Delhi, Nov 22
It is a new, convenient and safe formulation. Extensive clinical studies demonstrate that alfuzosin is highly selective resulting in lower incidence of side effects such as postural hypotension and syncope. Alfuzosin also has a low risk of sexual side effects whereas erectile dysfunction (ED) and ejaculatory disorders are well-recognised side effects of other alpha-blockers.
“The launch of Flotral further expands Ranbaxy’s key strategic product portfolio and establishes the company’s commitment to build its urology franchise through its competitive edge technology of NDDS,” Sanjeev I Dani, regional director-India, Ranbaxy, stated. |
. |
|
Ranbaxy Laboratories Limited, India's largest Rx pharmaceutical company, manufactures and markets branded generic drugs and Active Pharmaceutical Ingredients. Ranbaxy's continued focus on R&D has resulted in several approvals in developed markets and significant progress in New Drug Discovery Research. Ranbaxy's foray into Novel Drug Delivery Systems has led to proprietary "platform technologies" resulting in a number of products under development. The Company is selling its products in over 100 countries and has an expanding international portfolio of affiliates, joint ventures and alliances, ground operations in 34 countries and manufacturing operations in 7 countries.
HGH News Articles
|
. |
|Plan B Drug Side Effects
|Viagra Side Effects |
Premature ejaculation control |
|Doctor prescriptins |
Personal Training|
Copyright©, All Rights Reserved